300404.SZ · 博济医药
China A-shares · RS rating 96 · As of 2026-10-14
| Price | 12.86 CNY |
|---|---|
| 1-day change | -4.0% |
| RS rating (overall / 1M / 3M / 12M) | 96 / 79 / 96 / 85 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 32 / 39 / 26 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +6.3% |
| Distance from 52-week high | +26.9% |
| Market cap (USD) | $814.0M |